125 related articles for article (PubMed ID: 3557742)
1. Interactions of dihydralazine with furosemide in hypertonic patients.
Siegmund W; Kairies M; Franke G; Donner I; Biebler KE
Int J Clin Pharmacol Ther Toxicol; 1987 Mar; 25(3):148-51. PubMed ID: 3557742
[TBL] [Abstract][Full Text] [Related]
2. Emergency treatment of severe hypertension evaluated in a randomized study. Effect of rest and furosemide and a randomized evaluation of chlorpromazine, dihydralazine and diazoxide. Danish Multicenter Study.
Acta Med Scand; 1980; 208(6):473-80. PubMed ID: 7468317
[No Abstract] [Full Text] [Related]
3. Hydralazine and furosemide kinetics.
Nomura A; Yasuda H; Katoh K; Akimoto T; Miyazaki K; Arita T
Clin Pharmacol Ther; 1982 Sep; 32(3):303-6. PubMed ID: 7105621
[TBL] [Abstract][Full Text] [Related]
4. Dihydralazine therapy and acetylator phenotype.
Iisalo E; Laine T; Lehtonen A; Sellman R
Int J Clin Pharmacol Biopharm; 1979 Mar; 17(3):119-24. PubMed ID: 429082
[TBL] [Abstract][Full Text] [Related]
5. [Quantitative determination and kinetics of dihydralazine in hypertension patients].
Siegmund W; Zschiesche M; Kallwellis R; Franke G; Schneider T; Sill U; Scherber A; Hüller H
Pharmazie; 1985 Nov; 40(11):779-81. PubMed ID: 4095128
[TBL] [Abstract][Full Text] [Related]
6. Comparative study of oxdralazine and dihydralazine in essential hypertension.
Salvadeo A; Villa G; Segagni S; Piazza W; Criscuolo D
Int J Clin Pharmacol Ther Toxicol; 1981 Aug; 19(8):372-6. PubMed ID: 7030978
[TBL] [Abstract][Full Text] [Related]
7. [Comparison of the cardiac, renal and endocrine effects of converting enzyme inhibition with those of a classical triple therapy in experimental renal hypertension].
Dussaule JC; Michel JB; Auzan C; Alhenc-Gélas F; Corvol P; Ménard J
Arch Mal Coeur Vaiss; 1984 Oct; 77(11):1220-5. PubMed ID: 6098234
[TBL] [Abstract][Full Text] [Related]
8. The influence of the acetylator phenotype for the clinical use of dihydralazine.
Siegmund W; Franke G; Biebler KE; Donner I; Kallwellis R; Kairies M; Scherber A; Hüller H
Int J Clin Pharmacol Ther Toxicol; 1985 Apr; 23 Suppl 1():S74-8. PubMed ID: 3842694
[TBL] [Abstract][Full Text] [Related]
9. [Comparative hemodynamic effects of 2 vasodilators: dihydralazine and diltiazem in permanent essential arterial hypertension].
Levenson J; Simon A; Achimastos A; Temmar M; Safar M
Arch Mal Coeur Vaiss; 1982 Jun; 75 Spec No():167-70. PubMed ID: 6810821
[TBL] [Abstract][Full Text] [Related]
10. Acute effects of dihydralazine mesylate, furosemide, and metoprolol on maternal hemodynamics in pregnancy-induced hypertension.
Suonio S; Saarikoski S; Tahvanainen K; Pääkkönen A; Olkkonen H
Am J Obstet Gynecol; 1986 Jul; 155(1):122-5. PubMed ID: 3728580
[TBL] [Abstract][Full Text] [Related]
11. Double-blind comparison of dihydralazine and prazosin in hypertensive patients on the diuretic-reserpine regimen.
Salmela PI; Jounela AJ; Karppanen H
Ann Clin Res; 1981 Dec; 13(6):433-8. PubMed ID: 6753709
[No Abstract] [Full Text] [Related]
12. [A cross-over comparison of dihydralazine and minoxidil in severe hypertension (author's transl)].
Rumboldt Z; Jurisić M; Bagatin J
Lijec Vjesn; 1982 Feb; 104(2):64-8. PubMed ID: 7050574
[No Abstract] [Full Text] [Related]
13. Comparison of the antihypertensive activity of cadralazine (ISF 2469) and dihydralazine during chronic treatment.
Strocchi E; Costa FV; Caldari R; Malini PL; Marata AM; Parini J; Ambrosioni E
Int J Clin Pharmacol Ther Toxicol; 1983 Oct; 21(10):519-23. PubMed ID: 6642790
[TBL] [Abstract][Full Text] [Related]
14. [Treatment of hypertension with a drug combination, consisting of bemetizide, triamterene, dihydralazine and bupranolol (author's transl)].
Gasser RW; Brandstetter G; Skrabal F
Wien Klin Wochenschr; 1982 Jan; 94(1):25-8. PubMed ID: 7080491
[TBL] [Abstract][Full Text] [Related]
15. Cerebral symptoms and blood pressure during parenteral administration of chlorpromazine, dihydralazine and diazoxide. Danish multicenter study on acute severe hypertension.
Acta Med Scand Suppl; 1983; 678():51-60. PubMed ID: 6367380
[No Abstract] [Full Text] [Related]
16. Liquid chromatographic determination of dihydralazine and hydralazine in human plasma and its application to pharmacokinetic studies of dihydralazine.
Rouan MC; Campestrini J
J Pharm Sci; 1985 Dec; 74(12):1270-3. PubMed ID: 4087193
[TBL] [Abstract][Full Text] [Related]
17. [Dihydralazine and intracranial pressure. Risks in the treatment of patients with space-occupying, intracranial processes].
Dahlerup B; Laursen J
Ugeskr Laeger; 1987 Sep; 149(39):2589-91. PubMed ID: 3451489
[No Abstract] [Full Text] [Related]
18. [Kinetics of dihydralazine].
Siegmund WS; Huller H; Franke H; Kallwellis R; Lupke A
Farmakol Toksikol; 1982; 45(3):105-7. PubMed ID: 7095119
[No Abstract] [Full Text] [Related]
19. [Can lupus be caused by dihydralazine?].
Fakri E; François B
Nouv Presse Med; 1979 Nov; 8(45):3754. PubMed ID: 534238
[No Abstract] [Full Text] [Related]
20. Furosemide disposition in cirrhotic patients.
Sawhney VK; Gregory PB; Swezey SE; Blaschke TF
Gastroenterology; 1981 Dec; 81(6):1012-6. PubMed ID: 7286579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
